Medicine
Lopinavir and Ritonavir 200 mg/50 mg tablet
Lopinavir and Ritonavir 200 mg/50 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Lopinavir and Ritonavir Tablets USP, 100…
Key facts
- Active ingredient (INN)
- Lopinavir and Ritonavir
- Brand
- Sold under the generic name
- Strength
- 200 mg/50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 120 tablets, 8 blister pack, 60 tablets and 3 more
- Manufacturers
- Camber PharmaceuticalsIndiaLaurus LabsIndiaMacleods PharmaceuticalsIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Lopinavir and Ritonavir Tablets USP, 100 mg/25 mg Yellow, capsule shaped, biconvex film coated tablets, debossed with ‘H’ on one side and ‘L7’ on other side Bottles of 60 tablets (NDC 31722-603-60) Bottles of 120 tablets (NDC 31722-603-12) Recommended Storage Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR10 Lopinavir and Ritonavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 June 2021
- Identifiers
- RxCUI 597730, 746645DailyMed set ID 4e5005b8-f00c-4671-be09-bb927190760f, a7072c60-6dbf-4125-95e7-497c05a9e6a6, 115178c8-5ee2-4d96-820e-ea8264c1ac10NDC 31722-556, 42385-934, 33342-164Application ANDA091677, ANDA213857, ANDA204739
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 120 tablet, film coated in 1 bottle | 31722-556-12 | Camber PharmaceuticalsIndia | 7 June 2021 |
| 8 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 31722-556-31 | Camber PharmaceuticalsIndia | 7 June 2021 |
| 8 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 31722-556-32 | Camber PharmaceuticalsIndia | 7 June 2021 |
| 60 tablet, film coated in 1 bottle | 31722-556-60 | Camber PharmaceuticalsIndia | 7 June 2021 |
| 120 tablet, film coated in 1 bottle | 42385-934-12 | Laurus LabsIndia | 22 March 2022 |
| 60 tablet, film coated in 1 bottle | 33342-164-09 | Macleods PharmaceuticalsIndia | 25 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lopinavir and Ritonavir 200 mg/50 mg tablet.
Other strengths and forms of Lopinavir and Ritonavir
Clinical summary
Lopinavir and Ritonavir is a fixed-dose combination of a protease inhibitor and a cytochrome P450 3A inhibitor. It is available as tablets and oral solution. MedsAcross supplies Lopinavir and Ritonavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Lopinavir and RitonavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Kaletra prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
- Kaletra: European public assessment report (EPAR) · European Medicines Agency
- Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan): European public assessment report (EPAR) · European Medicines Agency
Need Lopinavir and Ritonavir 200 mg/50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.